Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Dr. Lal PathLabs Limited ( (IN:LALPATHLAB) ) has shared an announcement.
Dr. Lal PathLabs Limited has allotted 83,775,510 fully paid-up bonus equity shares of face value ₹10 each to its eligible shareholders in a 1:1 ratio, meaning one new share for every existing share held as of the record date of December 19, 2025. Following this bonus issue, the company’s paid-up equity share capital has doubled to ₹167.55 crore, divided into 16,75,51,020 fully paid-up equity shares, with the newly issued bonus shares ranking pari passu with the existing ones; the move broadens the company’s equity base and is likely aimed at enhancing liquidity and rewarding existing shareholders without altering their proportional ownership.
More about Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited is a listed Indian diagnostics company engaged in the business of providing pathology and laboratory testing services across the country. Its equity shares are traded on the National Stock Exchange of India and BSE under the symbol LALPATHLAB and scrip code 539524, respectively.
Average Trading Volume: 11,309
Technical Sentiment Signal: Hold
Current Market Cap: 233.3B INR
For a thorough assessment of LALPATHLAB stock, go to TipRanks’ Stock Analysis page.